![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KA Berg, S Maayani and WP Clarke
Department of Pharmacology, University of Texas Health Science Center at San Antonio 78284-7764, USA. berg@uthscsa.edu
We previously reported that in Chinese hamster ovary (CHO) cells, 5- hydroxytryptamine (5-HT)1B-like (CHO/5-HT1B) receptor-mediated inhibition of forskolin-stimulated cAMP accumulation is inhibited by activation of transfected human 5-HT2C receptors but not 5-HT2A receptors. In the current study, we investigated the mechanism involved in the regulation of receptor-mediated inhibition of adenylyl cyclase as a means to further elucidate differences between the signal transduction cascades of the 5-HT2A and 5-HT2C receptor subtypes. Activation of 5-HT2C receptors with 5-HT or (+/-)-1-(2,5-dimethoxy-4- iodophenyl)-2-aminopropane increased release of arachidonic acid via a phospholipase A2 (PLA2)-dependent mechanism. Incubation with (+/-)-1- (2,5-dimethoxy-4-iodophenyl)-2-aminopropane (1 microM) abolished 5- carboxamidotryptamine (5 nM)-mediated inhibition of forskolin- stimulated cAMP accumulation, which was blocked by the PLA2 inhibitor mepacrine (100 microM) and the cyclooxygenase inhibitor indomethacin (2 microM). Furthermore, purinergic receptor-mediated PLA2 activation as well as direct activation of PLA2 with melittin reduced CHO/5-HT1B responsiveness. These data indicate that activation of the PLA2/arachidonic acid signaling cascade mediates 5-HT2C receptor regulation of the CHO/5-HT1B receptor pathway. Consistent with our previous report and in contrast to activation of 5-HT2C or purinergic receptors, activation of 5-HT2A receptors had no effect on CHO/5-HT1B receptor function, although 5-HT2A receptor-mediated activation of PLA2 was measured. Interestingly, purinergic receptor-mediated inhibition of CHO/5-HT1B receptor function was blocked when 5-HT2A receptors were activated simultaneously. These data suggest that the lack of 5-HT2A mediated regulation of CHO/5-HT1B receptors may be due to activation of a third pathway (in addition to PLC and PLA2 pathways), which results in the inhibition of the production or the actions of a cyclooxygenase- dependent arachidonic acid metabolite.
This article has been cited by other articles:
|
|
 |
|
  A. Janoshazi, M. Deraet, J. Callebert, V. Setola, S. Guenther, B. Saubamea, P. Manivet, J.-M. Launay, and L. Maroteaux Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors Mol. Pharmacol., June 1, 2007; 71(6): 1463 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Turner and J. R. Raymond Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor: A PUTATIVE REGULATOR OF G PROTEIN COUPLING AND RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C J. Biol. Chem., September 2, 2005; 280(35): 30741 - 30750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Berg, K. L. J. Evans, J. D. Cropper, and W. P. Clarke Temporal Regulation of Agonist Efficacy at 5-Hydroxytryptamine (5-HT)1A and 5-HT1B Receptors J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Berg, B. D. Stout, S. Maayani, and W. P. Clarke Differences in Rapid Desensitization of 5-Hydroxytryptamine2A and 5-Hydroxytryptamine2C Receptor-Mediated Phospholipase C Activation J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 593 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. J. Evans, J. D. Cropper, K. A. Berg, and W. P. Clarke Mechanisms of Regulation of Agonist Efficacy at the 5-HT1A Receptor by Phospholipid-Derived Signaling Components J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1025 - 1035. [Abstract] [Full Text]
|
|
|
|
|
|
M. Chang, L. Zhang, J. P. Tam, and E. Sanders-Bush Dissecting G Protein-coupled Receptor Signaling Pathways with Membrane-permeable Blocking Peptides. ENDOGENOUS 5-HT2C RECEPTORS IN CHOROID PLEXUS EPITHELIAL CELLS J. Biol. Chem., March 15, 2000; 275(10): 7021 - 7029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Berg, B. D. Stout, J. D. Cropper, S. Maayani, and W. P. Clarke Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems Mol. Pharmacol., May 1, 1999; 55(5): 863 - 872. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. A. BERG, S. MAAYANI, J. GOLDFARB, and W. P. CLARKE Pleiotropic Behavior of 5-HT2A and 5-HT2C Receptor Agonists Ann. N.Y. Acad. Sci., December 15, 1998; 861(1): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. BERG, S. MAAYANI, and W. P. CLARKE Interactions between Effectors Linked to Serotonin Receptors Ann. N.Y. Acad. Sci., December 15, 1998; 861(1): 111 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tournois, V. Mutel, P. Manivet, J.-M. Launay, and O. Kellermann Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line. INVOLVEMENT OF ARACHIDONIC ACID METABOLISM J. Biol. Chem., July 10, 1998; 273(28): 17498 - 17503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W. P. Clarke Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus Mol. Pharmacol., July 1, 1998; 54(1): 94 - 104. [Abstract] [Full Text]
|
|
|
|
|
|
C. Becamel, A. Figge, S. Poliak, A. Dumuis, E. Peles, J. Bockaert, H. Lubbert, and C. Ullmer Interaction of Serotonin 5-Hydroxytryptamine Type 2C Receptors with PDZ10 of the Multi-PDZ Domain Protein MUPP1 J. Biol. Chem., April 13, 2001; 276(16): 12974 - 12982. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
